P4‐388: TRAILBLAZER‐ALZ (NCT03367403): A PHASE 2 DISEASE‐MODIFICATION COMBINATION THERAPY TRIAL TARGETING MULTIPLE MECHANISMS OF ACTION ALONG THE AMYLOID PATHWAY. (1st July 2006) - Irizarry, Michael C.; Fleisher, Adam S.; Hake, Ann Marie; Liu, Peng; Shcherbinin, Sergey; DeMattos, Ronald B.; Mintun, Mark A.; ,